These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22018831)

  • 21. Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.
    Al-Jefout M; Palmer J; Fraser IS
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):247-9. PubMed ID: 17550495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue.
    Lee KF; Lee YL; Chan RW; Cheong AW; Ng EH; Ho PC; Yeung WS
    Fertil Steril; 2010 Mar; 93(4):1052-60. PubMed ID: 19135668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response.
    Novembri R; Carrarelli P; Toti P; Rocha AL; Borges LE; Reis FM; Piomboni P; Florio P; Petraglia F
    Mol Hum Reprod; 2011 Sep; 17(9):587-93. PubMed ID: 21454316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: a new quantitative method.
    Nisolle M; Casanas-Roux F; Wyns C; de Menten Y; Mathieu PE; Donnez J
    Fertil Steril; 1994 Oct; 62(4):751-9. PubMed ID: 7523199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system.
    Peloggia A; Petta CA; Bahamondes L; Oliveira-Ribeiro M; Zhang J; Salamonsen L
    Hum Reprod; 2006 May; 21(5):1129-34. PubMed ID: 16436495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage expression in endometrium of women with and without endometriosis.
    Berbic M; Schulke L; Markham R; Tokushige N; Russell P; Fraser IS
    Hum Reprod; 2009 Feb; 24(2):325-32. PubMed ID: 19049988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device.
    Ferrero S; Tramalloni D; Venturini PL; Remorgida V
    Int J Gynaecol Obstet; 2011 May; 113(2):116-9. PubMed ID: 21333989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial.
    Wong AY; Tang LC; Chin RK
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):273-9. PubMed ID: 20618247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LCH, Chin RKH Aust N Z J Obstet Gynaecol 2010; 50 (3): 273-279.
    Basu A; Haran M; Nair A
    Aust N Z J Obstet Gynaecol; 2011 Feb; 51(1):97-8. PubMed ID: 21299520
    [No Abstract]   [Full Text] [Related]  

  • 32. Alteration of focal adhesion kinase expression in eutopic endometrium of women with endometriosis.
    Mu L; Zheng W; Wang L; Chen XJ; Zhang X; Yang JH
    Fertil Steril; 2008 Mar; 89(3):529-37. PubMed ID: 17543958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium.
    Barrier BF; Kendall BS; Ryan CE; Sharpe-Timms KL
    Hum Reprod; 2006 Apr; 21(4):864-9. PubMed ID: 16311290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
    Sheng J; Lu D; Zhang JP; Cui GF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KISS1/KISS1R expression in eutopic and ectopic endometrium of women suffering from endometriosis.
    Makri A; Msaouel P; Petraki C; Milingos D; Protopapas A; Liapi A; Antsaklis A; Magkou C; Koutsilieris M
    In Vivo; 2012; 26(1):119-27. PubMed ID: 22210725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
    Peng FS; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
    Taiwan J Obstet Gynecol; 2010 Jun; 49(2):160-4. PubMed ID: 20708521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two for the price of one.
    Samuel MI; Tenant-Flowers M; Kumar U; Taylor C
    Int J STD AIDS; 2008 Oct; 19(10):719-20. PubMed ID: 18824630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
    Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
    Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis.
    Nisolle M; Casanas-Roux F; Donnez J
    Fertil Steril; 1997 Nov; 68(5):912-9. PubMed ID: 9389825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.